Correlation between p53 and Mdm2 expression with histopathological parameters in cattle squamous cell carcinomas

por Al-Jameel, Waseem, Al-Mahmood, S. S., Al-Saidya, A. M.
Publicado 2022

The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance

por Al Fayi, Majed Saad, Gou, Xiaojun, Forootan, Shiva S., Al-Jameel, Waseem, Bao, Zhengzheng, Rudland, Philip R., Cornford, Philip A., Hussain, Syed A., Ke, Youqiang
Publicado 2016

Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5

por Al-Jameel, Waseem, Gou, Xiaojun, Forootan, Shiva S., Fayi, Majed Saad Al, Rudland, Philip S., Forootan, Farzad S., Zhang, Jiacheng, Cornford, Philip A., Hussain, Syed A., Ke, Youqiang
Publicado 2017

Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5

por Al-Jameel, Waseem, Gou, Xiaojun, Forootan, Shiva S., Fayi, Majed Saad Al, Rudland, Philip S., Forootan, Farzad S., Zhang, Jiacheng, Cornford, Philip A., Hussain, Syed A., Ke, Youqiang
Publicado 2020

Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter

por Forootan, Farzad S., Forootan, Shiva S., Gou, Xiaojun, Yang, Jin, Liu, Bichong, Chen, Danqing, Fayi, Majed Saad Al, Al-Jameel, Waseem, Rudland, Philip S., Hussain, Syed A., Ke, Youqiang
Publicado 2016

Inactivated FABP5 suppresses malignant progression of prostate cancer cells by inhibiting the activation of nuclear fatty acid receptor PPARγ

por Al-Jameel, Waseem, Gou, Xiaojun, Jin, Xi, Zhang, Jiacheng, Wei, Qiang, Ai, Jianzhong, Li, Hong, Al-Bayati, Asmaa, Platt-Higgins, Angela, Pettitt, Andrew, Rudland, Philip S., Ke, Youqiang
Publicado 2019